In this study we evaluate the feasibility of intraoperative visualization of penile and tongue tumours using the fluorescent tracer EMI-137.
This is a single-center, non-randomized, prospective interventional pilot study. Feasibility of intraoperatively visualizing tumour (margins) in penile and tongue tumours using EMI-137 will be investigated. Patients, ≥ 18 years of age, with ≥T1 penile or tongue cancer undergoing primary tumour surgery will be included. All patients will receive an intravenous bolus injection of EMI-137 prior to surgery. Main study parameters/endpoints are: Intraoperative visualization of primary penile or tongue tumours using a dedicated clinical fluorescence camera. The in vivo detected fluorescence signal will be correlated to ex vivo measurements and pathological assessment of the ex-cised tissue.
Study Type
OBSERVATIONAL
Enrollment
5
The Netherlands Cancer Institute / Antoni van Leeuwenhoek
Amsterdam, North Holland, Netherlands
tumour visualization by means of c-MET targeted fluores-cence imaging
The feasibility of intraoperative tumour visualization by means of c-MET targeted fluores-cence imaging will be evaluated, and the imaging result will be correlated to the level of c-MET expression determined using standard immunohistochemistry.
Time frame: peri-operative
Lymph node visualization by means of c-MET targeted fluores-cence imaging
Detection and visualization of lymph node metastases in penile and tongue tumour patients
Time frame: peri-operative
Dysplasia or Cis by means of c-MET targeted fluores-cence imaging
Identification of dysplasia or carcinoma in situ in penile and tongue tumours.
Time frame: Peri-operative
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.